Finance

Lists
2196:HKG
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
HK$17,22
+0,41%
(+0,070) 1D
16 ຕ.ລ., 14 ໂມງ 18 ນາທີ 28 ວິນາທີ GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2196...
Open
HK$17,32
High
HK$17,55
Low
HK$17,22
Mkt. cap
66,55 ຕື້
Avg. vol.
3,62 ລ້ານ
Volume
1,61 ລ້ານ
Dividend
2,61%
Quarterly dividend
HK$0,11
Ex-dividend date
27 ກ.ລ. 2026
P/E ratio
11,41
52-wk high
HK$24,84
52-wk low
HK$14,90
EPS
HK$1,51
Shares outstanding
551,94 ລ້ານ
No. of employees
41 ພັນ
Open
HK$17,32
High
HK$17,55
Low
HK$17,22
Mkt. cap
66,55 ຕື້
Avg. vol.
3,62 ລ້ານ
Volume
1,61 ລ້ານ
Dividend
2,61%
Quarterly dividend
HK$0,11
Ex-dividend date
27 ກ.ລ. 2026
P/E ratio
11,41
52-wk high
HK$24,84
52-wk low
HK$14,90
EPS
HK$1,51
Shares outstanding
551,94 ລ້ານ
No. of employees
41 ພັນ
News stories
From web sources and news partners
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs H
CEOLiu Yi | Wen Deyong
Employees40,7 ພັນ
Founded1994
Headquarters-
SectorPharmaceutical industry
Last report
25 ສ.ຫ. 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (CNY)
10,37 ຕື້ / 10,66 ຕື້
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
9,88 ຕື້
12,27 ຕື້
10,07 ຕື້
10,37 ຕື້
Cost of goods sold
5,08 ຕື້
5,65 ຕື້
5,07 ຕື້
5,23 ຕື້
Cost of revenue
5,08 ຕື້
5,65 ຕື້
5,07 ຕື້
5,23 ຕື້
Research and development expenses
1,01 ຕື້
1,28 ຕື້
896,79 ລ້ານ
1,19 ຕື້
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,10 ຕື້
4,44 ຕື້
3,27 ຕື້
3,35 ຕື້
Operating expense
4,04 ຕື້
5,92 ຕື້
4,19 ຕື້
4,63 ຕື້
Total operating expenses
9,12 ຕື້
11,57 ຕື້
9,26 ຕື້
9,86 ຕື້
Operating income
758,38 ລ້ານ
699,05 ລ້ານ
813,78 ລ້ານ
505,27 ລ້ານ
Other non operating income
-116,85 ລ້ານ
107,33 ລ້ານ
2,03 ລ້ານ
-13,28 ລ້ານ
EBT including unusual items
1,12 ຕື້
1,27 ຕື້
1,36 ຕື້
1,23 ຕື້
EBT excluding unusual items
1,49 ຕື້
1,10 ຕື້
1,21 ຕື້
1,07 ຕື້
Income tax expense
162,98 ລ້ານ
82,80 ລ້ານ
277,92 ລ້ານ
159,73 ລ້ານ
Effective tax rate
14,57%
6,50%
20,47%
13,00%
Other operating expenses
-92,19 ລ້ານ
117,57 ລ້ານ
19,04 ລ້ານ
74,01 ລ້ານ
Net income
821,33 ລ້ານ
847,27 ລ້ານ
870,83 ລ້ານ
850,64 ລ້ານ
Net profit margin
8,31%
6,91%
8,64%
8,20%
Earnings per share
-
-
-
-
Interest and investment income
1,05 ຕື້
732,13 ລ້ານ
689,67 ລ້ານ
938,86 ລ້ານ
Interest expense
-321,25 ລ້ານ
-291,32 ລ້ານ
-296,51 ລ້ານ
-310,88 ລ້ານ
Net interest expenses
727,28 ລ້ານ
440,80 ລ້ານ
393,16 ລ້ານ
627,98 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
1,39 ຕື້
1,47 ຕື້
1,59 ຕື້
1,24 ຕື້
Gain or loss from assets sale
2,12 ລ້ານ
-69,35 ລ້ານ
-
-195,23 ພັນ
AI content may include mistakes. Learn more
ແອັບຂອງ Google